NEXT Financial Group, Inc - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 91 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEXT Financial Group, Inc ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2021$1,0000.0%2000.0%0.00%
Q2 2021$1,0000.0%2000.0%0.00%
Q1 2021$1,0000.0%2000.0%0.00%
Q4 2020$1,0000.0%2000.0%0.00%
Q3 2020$1,0002000.0%0.00%
Q1 2020$0
-100.0%
2000.0%0.00%
Q4 2019$1,0002000.0%0.00%
Q3 2019$0
-100.0%
2000.0%0.00%
Q1 2019$1,0000.0%2000.0%0.00%
Q4 2018$1,000
-50.0%
2000.0%0.00%
-100.0%
Q3 2018$2,000
+100.0%
2000.0%0.00%
Q3 2017$1,000
-99.9%
2000.0%0.00%
Q2 2017$1,000,0000.0%2000.0%0.00%
Q1 2017$1,000,0002000.0%0.00%
Q4 2016$0
-100.0%
2000.0%0.00%
Q3 2016$1,0002000.0%0.00%
Q2 2016$02000.0%0.00%
Q1 2016$02000.0%0.00%
Q4 2015$0
-100.0%
2000.0%0.00%
Q3 2015$1,0002000.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2018
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 260,000$866,0000.34%
RTW INVESTMENTS, LP 5,978,355$19,908,0000.31%
GSA CAPITAL PARTNERS LLP 309,839$1,032,0000.17%
QCM Cayman, Ltd. 12,728$42,0000.13%
COWEN AND COMPANY, LLC 486,717$1,621,0000.11%
Hudson Bay Capital Management LP 1,400,000$4,662,0000.06%
Kerrisdale Advisers, LLC 208,150$693,0000.05%
Secure Asset Management, LLC 10,000$33,0000.02%
PDT Partners, LLC 72,500$241,0000.02%
Point72 Asset Management, L.P. 1,037,700$3,456,0000.02%
View complete list of ARBUTUS BIOPHARMA CORP shareholders